Your session is about to expire
← Back to Search
Participants for Transcranial Alternating Current Stimulation
N/A
Waitlist Available
Research Sponsored by University of Manitoba
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up before tacs, right after tacs, 30 minutes after tacs, and 1 hour after tacs
Awards & highlights
Study Summary
This trial is testing whether transcranial alternating current stimulation (tACS) or transcranial random noise stimulation (tRNS) can lower the resting and active motor thresholds. This would make it so that people with higher RMT and AMT would not need as high of intensities while stimulating the brain for treatments.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ before tacs, right after tacs, 30 minutes after tacs, and 1 hour after tacs
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~before tacs, right after tacs, 30 minutes after tacs, and 1 hour after tacs
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Resting Motor Threshold
Secondary outcome measures
Active Motor Threshold
Trial Design
1Treatment groups
Experimental Treatment
Group I: ParticipantsExperimental Treatment1 Intervention
Each participant will have their resting and active motor threshold measured using the transcranial magnetic stimulation (TMS) device. Participants will receive tACS for 10 minutes in the first session and tRNS in the second session.
Find a Location
Who is running the clinical trial?
University of ManitobaLead Sponsor
597 Previous Clinical Trials
199,426 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You have metal implants in your head or upper body.You have a pacemaker.You have a history of seizures.You have been diagnosed with a serious mental illness that affects your thoughts and behavior.You are currently pregnant.You have a brain injury.You take any medication on a daily basis for nervous system conditions such as depression, anxiety, sleep or pain.
Research Study Groups:
This trial has the following groups:- Group 1: Participants
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger